March 6, 2021 by Dr. Wolfgang Wodarg

On January 29, 2021, Mahmoud Ramadan Mohamed Elkazzaz from Kafrelsheikh University near Cairo registered a study with isotretinoin with the NIH Study Register under the number NTC04730895. This drug is intended to protect all vaccinated persons whose cells produce corona spikes after a gene vaccination from the expected serious side effects. This could be a hit, because there are already around 5 million people vaccinated in Germany who can experience the serious side effects that have been announced.

The registration for the study [i] states:

Isotretinoin (13-cis-retinoic acid) against spike protein-based vaccines for providing full protection against COVID-19 and preventing the expected serious long-term side effects of the spike protein-based vaccine.

The spike protein vaccine was soon approved as a stopgap solution and is now being introduced. The spike protein-based vaccine provides our cells with guidance and signals to express a component of the so-called “viral spike protein”. The strong interaction between angiotensin-converting enzyme 2 (ACE2) and the receptor binding domain (RBD) of the spike protein (SP) produced by the COVID-19 vaccine or found on the spike protein of the viral particles, has an affinity (~ 10 nM), and this binding affinity corresponds to that of many monoclonal antibodies (MAbs).

Therefore, the association of angiotensin-converting enzyme 2 (ACE2) with the binding domain of the spike protein is likely a strong and long-lived interaction and angiotensin-converting enzyme 2 (ACE2) is expected to invade antigen-presenting cells that are associated with the Spike protein of the COVID-19 vaccine or the spike protein of virus particles. (Translation and emphasis: WW)

The risk that the substance to be tested would like to reduce has been known for a few months. In a large Chinese study that was published in the Journal of Hematology & Oncology on September 4, 2020 [ii], well before the Covid-19 vaccines were approved or even used, it had been proven that the spikes of the coronaviruses if they get into the bloodstream, can cause great damage, e.g. through the smallest thrombosis in the capillaries of many organs. Such microthromboses are particularly to be feared in the lungs. The Chinese study and also a study by the Paul Ehrlich Institute[iii] were carried out to show the world how dangerous coronaviruses are.

Coronaviruses and their spikes themselves are dangerous too, but only if they get into the blood!

Fortunately, this is extremely rarely the case if the treatment or other circumstances have not circumvented or damaged the normally effective protective mechanisms in the upper airways.

Highly risky side effects of the genetic “vaccination” are kept secret!

The vaccination, however, bypasses the natural barriers against coronaviruses and goes directly into the shoulder muscle, which is well supplied with blood. It is not known for sure whether the dangerous spike proteins are only formed there, or whether other target cells are also stimulated to do so.

Such serious side effects of the ongoing corona vaccinations have so far been concealed by the responsible authorities (PEI, see below), denied (BASG see above) or suppressed (health authorities, public prosecutors). The Paul Ehrlich Institute did not even mention them in its work on the further risks of spike proteins (cell fusions) ( see below ).

In addition, there are dangerous immunological false alarms that can no longer be naturally controlled with life-threatening effects, as well as the risk of becoming a victim of ADE (Antibody Dependent Enhancement) in the event of subsequent contact with coronaviruses.

In the meantime, reports of high excess mortality among those vaccinated are piling up from Israel, Great Britain and Germany. A connection is criminally rarely thoroughly investigated, but consistently brushed aside as not given.

In view of the minimal additional protection provided by a vaccination, I consider the continuation of the vaccination campaigns irresponsible and demand that they STOP immediately.

[i] https://clinicaltrials.gov/ct2/show/NCT04730895

[ii] Zhang et al. Journal of Hematology & Oncology (2020) 13: 120, https://doi.org/10.1186/s13045-020-00954-7

[iii] Theuerkauf et al., iScience 24, 102170, March 19, 2021